Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK government

COPENHAGEN, Nov 2 (Reuters) – Bavarian Nordic has received a four-year contract from the British government for its vaccine against mpox and smallpox, the Danish vaccine maker said in a statement on Monday.

• Bavarian Nordic will supply its MVA-BN vaccine through scheduled deliveries

• The contract also includes optional flexibility provisions

• “It is vital to ensure that the UK has the right vaccines available to protect the public from a range of infectious disease threats,” the UK Health Security Agency said in the same statement

• Bavarian Nordic did not disclose the contract value

• Mpox is a viral disease that causes fever and skin lesions and spreads through close physical contact

(Reporting by Louise Rasmussen, editing by Stine Jacobsen)

Brought to you by www.srnnews.com

Click here to read the full article